Detection of lupus anticoagulant in patients attending an anticoagulation clinic P Chu, K Pendry, T E Blecher
The presence of the lupus anticoagulant is now known to indicate a tendency towards thromboses and recurrent abortions.' In patients with a history of thrombosis identifying the presence of lupus anticoagulant is clinically important as long term anticoagulation treatment should perhaps be considered. We determined the prevalence of lupus anticoagulant in selected patients attending an anticoagulation clinic.
Patients, methods, and results
About 1300 patients in total attend the anticoagulation clinic at this hospital. The following patients were selected to be screened for lupus anticoagulant: patients of any age with a history of recurrent thrombosis or an episode of thrombosis at a site other than veins of the legs, such as the axillary vein; patients aged less than 40 with a history of venous or arterial thrombosis in the absence of any known predisposing factors, such as the use of contraceptive pills, prolonged immobilisation, malignancy, obesity, or cardiac arrhythmias; and women with a history ofboth thrombosis and recurrent abortions or unexplained intrauterine death. The presence of lupus anticoagulant was detected by measuring the effect of patients' plasma on the kaolin clotting time of normal plasma.2 The patients were also screened for anticardiolipin antibodies.
We identified 29 patients who fulfilled the above criteria, comprising 12 men and 17 women with a median age of 36 (range 22-60). Nine of these patients (four men, five women) were found to be positive for lupus anticoagulant (figure) on two separate occasions. The 20 other patients were negative for it. Of the nine patients with lupus anticoagulant, three had a history of arterial thrombosis, of whom one had had two myocardial infarctions. Four had a history of recurrent venous thrombosis, and two had a history of both venous thrombosis and recurrent abortions. Seven were tested for anticardiolipin antibodies and five were found to have raised titres. One patient had coexisting thrombocytopenia, but none had any clinical history or laboratory features suggestive of systemic lupus erythematosus.
Comment
Our results show that the selection criteria that we used will identify a subpopulation ofpatients attending an anticoagulation clinic who have a surprisingly high prevalence of lupus anticoagulant (30%). This could be of considerable clinical value as the presence of lupus anticoagulant is increasingly appreciated as constituting a risk factor for thrombosis. Possibly such patients should be given prophylactic long term anticoagulation treatment.3 In the case ofpregnant patients such information would form a rational basis for advice on treatment. We emphasise, however, that our study was targeted at a highly selected group of patients, and the overall prevalence of lupus anticoagulant in unselected patients with thrombosis is as low as 2%.4
In conclusion, we recommend that screening certain selected patients attending anticoagulation clinics will identify several for whom long term anticoagulation treatment might be an advantage. 
